Seller record · Telehealth service
Synergy Rx
Fails 2 of 8 criteria. S5, analytical documentation: No certificate, lot number or testing claim appears on the site. Home, the terms, about and contact carry none. 1 more criterion also fails; see the table below.
At a glance
Synergy RxTelehealth service
- Price
- Not printed before a consultation or sign-up
- Sells
- semaglutide (brand and compounded), tirzepatide, NAD+, and 4 more
- FDA letters
- None on file
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A telehealth service selling GLP-1 programs and injectable peptides. It names prescribers and pharmacies, and withholds its GLP-1 price until consultation.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | Synergy Rx's website |
| S2 | Prescription gating | PASS | Synergy Rx's website |
| S3 | Pharmacy identification | PASS | Synergy Rx's website |
| S4 | Compounding disclosure | PASS | Synergy Rx's website |
| S5 | Analytical documentation | FAIL | Synergy Rx's terms |
| S6 | Business address | PASS | Synergy Rx's terms |
| S7 | Price disclosure | FAIL | Synergy Rx's website |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date. A row that was re-checked later states its own date.
Products shown on the seller's own pages at the recorded date: semaglutide (brand and compounded), tirzepatide, NAD+, sermorelin, glutathione, B-12, PT-141.
Other sellers of the same products
Who sells semaglutideWho sells tirzepatideWho sells sermorelinWho sells NAD+Who sells glutathioneWho sells PT-141
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.